PT Charlie Hospital Semarang Tbk (ISX:RSCH) ROCE %: -6.24% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:RSCH PT Charlie Hospital Semarang Tbk ISX:RSCH
23 GF Score
Price Rp450.00
! 1 Warning Sign
View Full Analysis

What is PT Charlie Hospital Semarang Tbk ROCE %?

PT Charlie Hospital Semarang Tbk ISX:RSCH -0.45% 23 ROCE % is -6.24% as of Jun. 2026. GuruFocus rates ISX:RSCH with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Charlie Hospital Semarang Tbk's annualized ROCE % for the quarter that ended in Jun. 2026 was -6.24%.

PT Charlie Hospital Semarang Tbk  (ISX:RSCH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PT Charlie Hospital Semarang Tbk ROCE % Related Terms

PT Charlie Hospital Semarang Tbk ROCE % Historical Data

* Premium members only.

The historical data trend for PT Charlie Hospital Semarang Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Charlie Hospital Semarang Tbk ROCE % Chart

PT Charlie Hospital Semarang Tbk Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 5.27 -10.67 -1.09 -1.58 -5.96

PT Charlie Hospital Semarang Tbk Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.77 -3.29 0.49 -8.07 -6.24
ISX:RSCH
23GF Score
PT Charlie Hospital Semarang Tbk ISX:RSCH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Charlie Hospital Semarang Tbk ROCE % Calculation

PT Charlie Hospital Semarang Tbk's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-10446.412505/( ( (192466.455817 - 10693.679352) + (202554.017715 - 33946.410644) )/ 2 )
=-10446.412505/( (181772.776465+168607.607071)/ 2 )
=-10446.412505/175190.191768
=-5.96 %

PT Charlie Hospital Semarang Tbk's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=-10016.497584/( ( (198648.788319 - 34986.304805) + (191232.635448 - 34061.108615) )/ 2 )
=-10016.497584/( ( 163662.483514 + 157171.526833 )/ 2 )
=-10016.497584/160417.0051735
=-6.24 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -6.24% mean?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a ROCE % of -6.24% as of Jun. 2026.
Is PT Charlie Hospital Semarang Tbk's ROCE % too high?
PT Charlie Hospital Semarang Tbk's current ROCE % is -6.24%. Overall, PT Charlie Hospital Semarang Tbk has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does PT Charlie Hospital Semarang Tbk's ROCE % compare to HCA and THC?
PT Charlie Hospital Semarang Tbk's ROCE % of -6.24% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.32, based on 654 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Charlie Hospital Semarang Tbk's current ROCE % is -6.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Charlie Hospital Semarang Tbk stock overvalued right now?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a current ROCE % of -6.24%. The current ROCE % is -6.24%. PT Charlie Hospital Semarang Tbk's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PT Charlie Hospital Semarang Tbk (ISX:RSCH), the current ROCE % is -6.24% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Charlie Hospital Semarang Tbk Business Description

Address Raya Ngabean Road, Lot 1A, Ngabean Village, Boja District, Kendal Regency, Central Java, Jawa, IDN, 51381
PT Charlie Hospital Semarang Tbk operates a private hospital in Kendal Regency, Central Java, Indonesia, classified as a Type D facility serving the local community. Its medical services include a 24-hour emergency room, specialist polyclinics, a central surgical installation, an intensive care unit, perinatology, laboratory, radiology, and pharmacy, along with other supporting facilities. The company reports in three segments: hospital services, comprising medical goods and services provided to outpatients and inpatients; construction materials trading; and construction activities, which cover services rendered on a fee or contract basis as well as the construction, maintenance, or reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment, sports, and other buildings. Revenue is generated primarily from patient care fees and related medical services, supplemented by sales of construction materials and construction contract work.
23GF Score

Get the complete analysis for ISX:RSCH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp450.00
Price